IC-OS Case Review Webinar - December 2021 - Practical Considerations in Cardio-Oncology Drug Interactions: A Case-Based Series
Details
Organised by
Date
- America/New_York
Daniel Lenihan
Dr Lenihan has been active in cardio-oncology and heart failure, for over 20 years. The main...
Read MoreDr Lenihan has been active in cardio-oncology and heart failure, for over 20 years. The main focus of these efforts have included hemodynamic assessments, angiogenic growth factor response, novel cardiac biomarkers as well as optimal methods to prevent or detect heart failure at the earliest stage possible in patients undergoing treatment for cancer. His current research projects include early phase clinical trials in cardio-oncology, heart failure and amyloidosis. He is the Principal Investigator of the PROTECT study looking at cardiac safety in patients undergoing proteasome inhibitor treatment for relapsed multiple myeloma and the recently completed PREDICT study, a large multicenter prospective study examining the role of cardiac biomarkers for the detection of cardiotoxicity during anthracycline based therapy. In addition, he is intimately involved in the latest treatment trials for cardiac amyloidosis. He was recently at Washington University in St Louis to enhance and expand the Cardio-Oncology Center of Excellence. He is at the forefront of concerted efforts to develop a viable Cardio-Oncology fellowship training program and continues to foster collaboration among a host of colleagues both regionally, nationally, and throughout the world. He is the current President of the International Cardio-Oncology Society (ICOS),www.IC-OS.org, which is an international professional association whose primary goal is to eliminate cardiac disease as a barrier to effective cancer therapy.
Show LessJo Ellen Rodgers
Dr. Rodgers is currently a professor at UNC Eshelman School of PHarmacy where she serves Director...
Read MoreDr. Rodgers is currently a professor at UNC Eshelman School of PHarmacy where she serves Director of Postgraduate Education. She is board certified in both cardiology and pharmacotherapy and is a fellow of the American College of Clinical Pharmacy, the Heart Failure Society of America, and the American Heart Association.
Show LessPreston Skersick
Preston Skersick is a first-year U.S. Medical Affairs Fellow with the University of North...
Read MorePreston Skersick is a first-year U.S. Medical Affairs Fellow with the University of North Carolina and GlaxoSmithKline. Originally from Indiana, Preston spent the last 10 years in the state of Georgia where he received his Bachelors of Science in Chemistry from Georgia College & State University. In May of 2021, he graduated from the Mercer University College of Pharmacy in Atlanta, GA with his Doctorate of Pharmacy. The first year of Preston’s fellowship has focused on cardiology and cardio-oncology.
Show LessSarah Maryon Hayes
Sarah is a Board-Certified Oncology Pharmacist at North Memorial Health Care in Minneapolis, MN....
Read MoreSarah is a Board-Certified Oncology Pharmacist at North Memorial Health Care in Minneapolis, MN. She is passionate about patient-directed cancer care and late-breaking research in clinical pharmacy, inpatient supportive care, and Hematology/Oncology practice. She completed her PGY-2 Hematology/Oncology Residency at the University of Minnesota Medical Center and serves as a lecturer at the University of Minnesota College of Pharmacy.
Show LessStephen Casselli
Dr. Stephen Casselli is an executive director at International Cardio-Oncology Society.
Read MoreDr. Stephen Casselli is an executive director at International Cardio-Oncology Society.
Show Less